Seminars in Nephrology
Volume 24, Issue 3 , Pages 287-291 , May 2004

Recurrent IgA nephropathy after renal transplantation

  • Jürgen Floege

      Affiliations

    • Division of Nephrology and Immunology, University of Aachen, Aachen, Germany
    • Corresponding Author InformationAddress reprint requests to Jürgen Floege, MD, Medizinische Klinik II, Klinikum der RWTH, Pauwelsstr. 30, D-52057 Aachen, Germany

References 

  1. Briganti EM, Russ GR, McNeil JJ, Atkins RC, Chadban SJ. Risk of renal allograft loss from recurrent glomerulonephritis. N Engl J Med. 2002;347:103–109
  2. Hariharan S, Johnson CP, Bresnahan BA, Taranto SE, McIntosh MJ, Stablein D. Improved graft survival after renal transplantation in the United States, 1988 to 1996. N Engl J Med. 2000;342:605–612
  3. Floege J, Feehally J. IgA nephropathy (Recent developments). J Am Soc Nephrol. 2000;11:2395–2403
  4. Donadio JV, Grande JP. IgA nephropathy. N Engl J Med. 2002;347:738–748
  5. Odum J, Peh CA, Clarkson AR, et al.  Recurrent mesangial IgA nephritis following renal transplantation. Nephrol Dial Transplant. 1994;9:309–312
  6. Berger J, Yaneva H, Nabarra B, Barbanel C. Recurrence of mesangial deposition of IgA after renal transplantation. Kidney Int. 1975;7:232–241
  7. Berger J. Recurrence of IgA nephropathy in renal allografts. Am J Kidney Dis. 1988;12:371–372
  8. Kessler M, Hiesse C, Hestin D, Mayeux D, Boubenider K, Charpentier B. Recurrence of immunoglobulin A nephropathy after renal transplantation in the cyclosporine era. Am J Kidney Dis. 1996;28:99–104
  9. Frohnert PP, Donadio JV, Velosa JA, Holley KE, Sterioff S. The fate of renal transplants in patients with IgA nephropathy. Clin Transplant. 1997;11:127–133
  10. Ohmacht C, Kliem V, Burg M, et al.  Recurrent immunoglobulin A nephropathy after renal transplantation (A significant contributor to graft loss). Transplantation. 1997;64:1493–1496
  11. Bumgardner GL, Amend WC, Ascher NL, Vincenti FG. Single-center long-term results of renal transplantation for IgA nephropathy. Transplantation. 1998;65:1053–1060
  12. Freese P, Svalander C, Norden G, Nyberg G. Clinical risk factors for recurrence of IgA nephropathy. Clin Transplant. 1999;13:313–317
  13. Kim YS, Moon JI, Jeong HJ, et al.  Live donor renal allograft in end-stage renal failure patients from immunoglobulin A nephropathy. Transplantation. 2001;71:233–238
  14. Andresdottir MB, Hoitsma AJ, Assmann KJ, Wetzels JF. Favorable outcome of renal transplantation in patients with IgA nephropathy. Clin Nephrol. 2001;56:279–288
  15. Wang AY, Lai FM, Yu AW, et al.  Recurrent IgA nephropathy in renal transplant allografts. Am J Kidney Dis. 2001;38:588–596
  16. Ponticelli C, Traversi L, Feliciani A, Cesana BM, Banfi G, Tarantino A. Kidney transplantation in patients with IgA mesangial glomerulonephritis. Kidney Int. 2001;60:1948–1954
  17. Park SB, Joo I, Suk J, et al.  IgA nephropathy in renal transplant recipients (Is it a significant cause of allograft failure?). Transplant Proc. 1996;28:1540–1542
  18. Streather CP, Scoble JE. Recurrent IgA nephropathy in a renal allograft presenting as crescentic glomerulonephritis. [Letter] Nephron. 1994;66:113–114
  19. Coppo R, Amore A, Cirina P, et al.  Characteristics of IgA and macromolecular IgA in sera from IgA nephropathy transplanted patients with and without IgAN recurrence. Contrib Nephrol. 1995;111:85–92
  20. Kimata N, Tanabe K, Ishikawa N, et al.  Correlation between proteinuria and prognosis of transplant IgA nephropathy. Transplant Proc. 1996;28:1537–1539
  21. Briggs JD, Jones E. Recurrence of glomerulonephritis following renal transplantation. Scientific Advisory Board of the ERA-EDTA Registry. European Renal Association-European Dialysis and Transplant Association Nephrol Dial Transplant. 1999;14:564–565
  22. Lim EC, Chia D, Gjertson DW, Koka P, Terasaki PI. In vitro studies to explain high renal allograft survival in IgA nephropathy patients. Transplantation. 1993;55:996–999
  23. Scolari F. Familial IgA nephropathy. J Nephrol. 1999;12:213–219
  24. Schena FP, Cerullo G, Rossini M, Lanzilotta SG, D’Altri C, Manno C. Increased risk of end-stage renal disease in familial IgA nephropathy. J Am Soc Nephrol. 2002;13:453–460
  25. Floege J. Evidence-based recommendations for immunosuppression in IgA-nephropathy (Handle with caution). Nephrol Dial Transplant. 2003;18:241–245
  26. Oka K, Imai E, Moriyama T, et al.  A clinicopathological study of IgA nephropathy in renal transplant recipients (beneficial effect of angiotensin-converting enzyme inhibitor). Nephrol Dial Transplant. 2000;15:689–695
  27. Donadio JV, Grande JP, Bergstralh EJ, Dart RA, Larson TS, Spencer DC. The long-term outcome of patients with IgA nephropathy treated with fish oil in a controlled trial. Mayo Nephrology Collaborative Group J Am Soc Nephrol. 1999;10:1772–1777
  28. Dillon JJ. Fish oil therapy for IgA nephropathy (Efficacy and interstudy variability). J Am Soc Nephrol. 1997;8:1739–1744
  29. Nowack R, Birck R, van der Woude FJ. Mycophenolate mofetil for systemic vasculitis and IgA nephropathy. [Letter] Lancet. 1997;349:774
  30. Ziswiler R, Steinmann-Niggli K, Kappeler A, Daniel C, Marti HP. Mycophenolic acid (A new approach to the therapy of experimental mesangial proliferative glomerulonephritis). J Am Soc Nephrol. 1998;9:2055–2066
  31. Maes BD, Evenepoel P, Kuypers D, et al.  A prospective placebo-controlled randomized single center study of mycophenolate mofetil treatment for IgA nephropathy (Lack of clinical efficacy after two years). [Abstract] J Am Soc Nephrol. 2001;12:114A
  32. Manu MA, Tanabe K, Ishikawa N, et al.  Tacrolimus rescue for resistant rejection, chronic rejection, and immunoglobulin A nephropathy of renal allografts under primary cyclosporine A immunosuppression. Transplant Proc. 1999;31:2853–2855
  33. Meulders Q, Pirson Y, Cosyns JP, Squifflet JP, van Ypersele de Strihou C. Course of Henoch-Schönlein nephritis after renal transplantation (Report on ten patients and review of the literature). Transplantation. 1994;58:1179–1186
  34. Haubitz M, Kliem V, Koch KM, et al.  Renal transplantation for patients with autoimmune diseases (single-center experience with 42 patients). Transplantation. 1997;63:1251–1257
  35. Pillebout E, Thervet E, Hill G, Alberti C, Vanhille P, Nochy D. Henoch-Schönlein purpura in adults (Outcome and prognostic factors). J Am Soc Nephrol. 2002;13:1271–1278

PII: S0270-9295(04)00010-5

doi: 10.1016/j.semnephrol.2004.01.008

Seminars in Nephrology
Volume 24, Issue 3 , Pages 287-291 , May 2004

Article Tools